Healthcare Services Group HCSG Short-term restricted investments

Short-term restricted investments at other companies

UroGen PharmaURGN

$177K+0.6%

Intercontinental ExchangeICE

$884M+43.3%

UFP Industries, Inc.UFPI

$51.3M+22.0%

IngevityNGVT

$24.7M—

Taboola.com Ltd.TBLA

$1.46M0.0%

Construction PartnersROAD

$16.15M-20.1%

Other financials

Income statement

See full

Revenue$462.8M+3.4%

Gross profit$75.8M+11.6%

Net income$26.1M+51.3%

EPS (diluted)$0.37+60.9%

Balance sheet

See full

Cash & equivalents$136.2M+112%

Total debt$14.7M-11.1%

Total equity$513.8M-0.1%

Total assets$814.8M-1.0%

Cash flow

See full

Operating cash flow$43.7M+59.0%

CapEx$1.4M-19.8%

Free cash flow$42.3M+64.3%

Valuation

See full

Market cap$1.62B+76.0%

Enterprise value$1.5B+70.6%

P/E23.8×+1.6×

P/S0.9×+0.3×

Profitability

See full

Gross margin13.3%0.0pp

Net margin3.7%+1.3pp

FCF margin8.4%—

Returns & leverage

See full

Return on equity13.2%+4.8pp

Debt / equity0×0.0×

Current ratio3.1×+0.2×

Where this comes from

Reported directly by Healthcare Services Group in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestmentsCurrent.

The official record: Healthcare Services Group’s 10-Q, filed April 24, 2026, on SEC EDGAR. View the filing →

Ask your AI about Healthcare Services Group's short-term restricted investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Healthcare Services Group's short-term restricted investments?: Healthcare Services Group (HCSG) reported short-term restricted investments of $35.9M in Q1 2026.
How has Healthcare Services Group's short-term restricted investments changed year-over-year?: Healthcare Services Group's short-term restricted investments increased by 23.6% year-over-year, from $29.05M to $35.9M.